Since April 2020, the S&P 500 has delivered a total return of 101%. But one standout stock has more than doubled the market - over the past five years, Cencora has surged 231% to $285.36 per share.

We came across a bullish thesis on Cencora, Inc. (COR) on Substack by Hidden Market Gems. In this article, we will summarize ...

AmerisourceBergen’s move into the digital health area is part of a revamp of the business, which will be renamed Cencora later this year to reflect a change in business strategy, with ...

Formerly known as AmerisourceBergen until its 2023 rebranding, Cencora (NYSE:COR) is a global pharmaceutical distribution company that connects manufacturers with healthcare providers while ...

In January, Cramer stated: “Cencora, Conshohocken… Used to be the old ABC, AmerisourceBergen. I have to tell you, I think that Steve Collis is really, really smart. I met him last year at the ...

Pharma distributor AmerisourceBergen is working on a platform to make access to digital therapeutics (DTx) easier in the US by providing a unified system for ordering, dispensing and fulfilment.

Morgan Stanley analyst Erin Wright raised the firm’s price target on Cencora (COR) to $288 from $263 and keeps an Equal Weight rating on the shares. While policy will be “front and center ...